Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19)

被引：35
|
作者：
Abedi, Farshad [1 ]
Rezaee, Ramin [2 ,3 ]
Karimi, Gholamreza [1 ,4 ]
机构：
[1] Mashhad Univ Med Sci, Inst Pharmaceut Technol, Pharmaceut Res Ctr, Mashhad, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Clin Res Unit, Fac Med, Mashhad, Razavi Khorasan, Iran
[3] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Razavi Khorasan, Iran
[4] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmacodynam & Toxicol, Mashhad, Razavi Khorasan, Iran
来源：
PHARMACOLOGICAL RESEARCH | 2020年 / 156卷
关键词：
D O I：
10.1016/j.phrs.2020.104808
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody: Seroprevalence among Contacts of COVID-19 Cases
    Prakash, Om
    Solanki, Bhavin
    Sheth, Jay Kirtikumar
    Kadam, Mina
    Vyas, Sheetal
    INDIAN JOURNAL OF PUBLIC HEALTH, 2021, 65 (01) : 5 - 10
  • [32] SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ISOLATION FROM PLEURAL FLUID WITH COVID-19 PNEUMONIA AND SUPERIMPOSED EMPYEMA
    Leys, Lorenzo
    Donaldson, Sahai
    Rougui, Lamiaa
    Poddar, Vishal
    CHEST, 2020, 158 (04) : 574A - 574A
  • [33] Challenges and complexities in evaluating severe acute respiratory syndrome coronavirus 2 molecular diagnostics during the COVID-19 pandemic
    Scott, Lesley E.
    Noble, Lara D.
    Singh-Moodley, Ashika
    Kahamba, Trish
    Hardie, Diana R.
    Preiser, Wolfgang
    Stevens, Wendy S.
    AFRICAN JOURNAL OF LABORATORY MEDICINE, 2022, 11 (01)
  • [34] Preparedness of nuclear medicine departments during the severe acute respiratory syndrome-Coronavirus-2 (COVID-19) pandemic
    Singh, Harmandeep
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2020, 35 (03): : 194 - 196
  • [35] Immunization against severe acute respiratory syndrome Coronavirus 2: an overview
    El-Masry, Eman A.
    AFRICAN HEALTH SCIENCES, 2021, 21 (04) : 1574 - 1583
  • [36] Immune response against the severe acute respiratory syndrome coronavirus 2
    Ferenc, Uher
    Zsolt, Matula
    Marton, Gonczi
    Laszlo, Gopcsa
    Gabriella, Beko
    Marienn, Reti
    Zoltan, Szekanecz
    Eva, Ajzner
    Istvan, Valyi-Nagy
    ORVOSI HETILAP, 2022, 163 (20) : 774 - 787
  • [37] Hybrid Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2
    Russell, Rodney S.
    VIRAL IMMUNOLOGY, 2022, 35 (06) : 391 - 391
  • [38] Epidemiological survey on the benefit of neuraminidase inhibitors on severe acute respiratory syndrome due to COVID-19
    Flores, Thamara Graziela
    Goncalves, Carlos Fernando Antunes
    Volpato, Isis Niero
    Barbisan, Fernanda
    Lampert, Melissa Agostini
    da Cruz, Ivana Beatrice Manica
    Bonotto, Nathalia Cardoso de Afonso
    REVISTA DE EPIDEMIOLOGIA E CONTROLE DE INFECCAO, 2023, 13 (01):
  • [39] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Sequence Characteristics of Coronavirus Disease 2019 (COVID-19) Persistence and Reinfection
    Choudhary, Manish C.
    Crain, Charles R.
    Qiu, Xueting
    Hanage, William
    Li, Jonathan Z.
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (02) : 237 - 245
  • [40] Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) – anatomic pathology perspective on current knowledge
    Sambit K. Mohanty
    Abhishek Satapathy
    Machita M. Naidu
    Sanjay Mukhopadhyay
    Shivani Sharma
    Lisa M. Barton
    Edana Stroberg
    Eric J. Duval
    Dinesh Pradhan
    Alexandar Tzankov
    Anil V. Parwani
    Diagnostic Pathology, 15
12345